Captrust Financial Advisors reduced its holdings in The Carlyle Group Inc. (NASDAQ:CG – Free Report) by 43.4% during the 3rd quarter, Holdings Channel reports. The fund owned 6,980 shares of the financial services provider’s stock after selling 5,347 shares during the period. Captrust Financial Advisors’ holdings in The Carlyle Group were worth $301,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also modified their holdings of CG. Tobam purchased a new position in shares of The Carlyle Group in the 2nd quarter valued at about $27,000. Blue Trust Inc. raised its stake in shares of The Carlyle Group by 506.3% during the 2nd quarter. Blue Trust Inc. now owns 770 shares of the financial services provider’s stock worth $31,000 after buying an additional 643 shares during the period. Brooklyn Investment Group purchased a new position in shares of The Carlyle Group during the 3rd quarter valued at approximately $33,000. Rothschild Investment LLC acquired a new stake in The Carlyle Group in the 2nd quarter valued at $50,000. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its position in The Carlyle Group by 1,600.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,700 shares of the financial services provider’s stock worth $73,000 after acquiring an additional 1,600 shares during the period. Hedge funds and other institutional investors own 55.88% of the company’s stock.
Insiders Place Their Bets
In other The Carlyle Group news, Director Daniel A. D’aniello sold 495,542 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $51.53, for a total transaction of $25,535,279.26. Following the sale, the director now owns 32,504,102 shares of the company’s stock, valued at approximately $1,674,936,376.06. This trade represents a 1.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Carlyle Group Inc. sold 924,466 shares of the stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $2.14, for a total transaction of $1,978,357.24. Following the completion of the transaction, the insider now directly owns 3,643,231 shares in the company, valued at $7,796,514.34. This trade represents a 20.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,171,556 shares of company stock worth $29,222,475 in the last quarter. 27.20% of the stock is owned by company insiders.
The Carlyle Group Stock Performance
The Carlyle Group (NASDAQ:CG – Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The financial services provider reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.08. The Carlyle Group had a net margin of 2.21% and a return on equity of 24.91%. The firm had revenue of $895.00 million during the quarter, compared to analysts’ expectations of $908.17 million. During the same quarter in the previous year, the business posted $0.87 earnings per share. The business’s quarterly revenue was up 15.2% compared to the same quarter last year. As a group, sell-side analysts forecast that The Carlyle Group Inc. will post 3.77 earnings per share for the current year.
The Carlyle Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 18th were paid a dividend of $0.35 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.40 annualized dividend and a yield of 2.66%. The Carlyle Group’s payout ratio is 482.76%.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on CG shares. UBS Group boosted their target price on shares of The Carlyle Group from $43.00 to $54.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 22nd. Keefe, Bruyette & Woods raised their target price on The Carlyle Group from $51.00 to $55.00 and gave the company a “market perform” rating in a research report on Friday, November 8th. Barclays boosted their price target on The Carlyle Group from $57.00 to $59.00 and gave the stock an “overweight” rating in a research report on Monday, December 9th. Evercore ISI raised their price objective on The Carlyle Group from $45.00 to $47.00 and gave the company an “in-line” rating in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. raised their target price on shares of The Carlyle Group from $44.00 to $50.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 23rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $54.00.
Check Out Our Latest Research Report on The Carlyle Group
The Carlyle Group Profile
The Carlyle Group Inc is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES.
Featured Articles
- Five stocks we like better than The Carlyle Group
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding CG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Carlyle Group Inc. (NASDAQ:CG – Free Report).
Receive News & Ratings for The Carlyle Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Carlyle Group and related companies with MarketBeat.com's FREE daily email newsletter.